Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R21)

The summary for the Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R21): The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Aging (NIA), and the National Cancer Institute (NCI) invite investigator-initiated research projects focused on elucidating the various roles of ubiquitin and ubiquitin-like modifications in the development, normal physiology and/or disease progression in cells, organs, and tissues of interest to NIDDK, NCI, and NIA. The NIDDK supports research pertaining to diabetes, endocrine and metabolic diseases; nutritional disorders, obesity and digestive diseases; and kidney, urologic and hematologic diseases. The NIA supports research pertaining to the basic biology of aging and age-associated diseases in various models including, but not limited to, tissue culture models and other cell-based paradigms, and tissues such as heart, muscle, brain and prostate. The Division of Cancer Biology of the NCI supports basic research projects covering a broad spectrum of topics directed at understanding the biological basis of cancer.
Federal Grant Title: Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education Food and Nutrition
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-168
Type of Funding: Grant
CFDA Numbers: 93.39693.847
CFDA Descriptions: Cancer Biology Research 93.847 Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Feb 28, 2006
Creation Date: Jun 07, 2006
Archive Date: Aug 02, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.848 -- Digestive Diseases and Nutrition Research
Applicants Eligible for this Grant
County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Special district governments City or township governments Public housing authorities/Indian housing authorities State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 ...
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Scree...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com